VULVAR SQUAMOUS CELL CARCINOMA
Clinical trials for VULVAR SQUAMOUS CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new VULVAR SQUAMOUS CELL CARCINOMA trials appear
Sign up with your email to follow new studies for VULVAR SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for tough cancers: EVOLVE104 trial begins
Disease control Recruiting nowThis early-phase study tests a new drug called EVOLVE104 in people with advanced bladder cancer or several types of squamous cell cancers (lung, esophagus, skin, and others) that have not responded to standard treatments. About 160 participants will receive the drug to see if it …
Matched conditions: VULVAR SQUAMOUS CELL CARCINOMA
Phase: PHASE1 • Sponsor: EvolveImmune United, Inc • Aim: Disease control
Last updated May 07, 2026 18:42 UTC
-
Vulvar cancer breakthrough: personalizing surgery with HPV and p53
Knowledge-focused Recruiting nowThis study looks at whether the type of early-stage vulvar cancer (based on HPV and p53 status) needs more or less surgery than usual. About 249 participants will have their cancer removed and be followed for 3 years to see if the cancer comes back. The goal is to tailor treatmen…
Matched conditions: VULVAR SQUAMOUS CELL CARCINOMA
Phase: NA • Sponsor: Canadian Cancer Trials Group • Aim: Knowledge-focused
Last updated May 13, 2026 16:11 UTC